The Protein Myth: Our Obsession With Protein and How It Is Killing US

Houston Methodist

G. Davis

Early-Onset CRC: A New Epidemic With Knowns and Unknowns

Ibrahim Sahin

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

Cancer Screening Molecular Tools

Fengting Yan

Year in Review: Colorectal Cancer

Moffitt Cancer Center

R. Kim, T. Biachi

The Importance of 1L Biomarkers in CRC

Nicholas DeVito

Young Onset Colorectal Cancer: A New Epidemic?

Ibrahim Sahin

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON-BTC-…

Insights from 2023 ASCO® Annual Meeting

R. Kim, R. Mehta

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

Colon Polyp with Carcinoma In-Situ, Intramucosal Cancer or Invasive …

Florida Gastroenterologic Society

D. Yang

ESMO 2024 Summary: Neoadjuvant Colon Cancer Treatment - Recent Clini…

2024 ESMO Annual Meeting Insights Hub

J. Taieb

ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckMate 8…

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

ASCO GI 2023 Conference Coverage

N. Uboha, A. Turk, K. Spencer, M. Cecchini

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

Treating KRAS-Mutated mCRC

Ibrahim Sahin

ASCO GI 2023 Key Studies

ASCO GI 2023 Conference Coverage

R. Kim, R. Mehta

2024 Updates on 1L MSI-H/dMMR mCRC and Using ctDNA MRD Testing in Ea…

Total Health

A. Grothey

Using ctDNA to Guide Adjuvant Therapy in GI Malignancies

University of Miami Sylvester Comprehensive Cancer Center

P. Hosein